exosomes
exosomes
产品管线 / Pipeline
公司产品管线分为两大核心板块——免疫细胞管线与干细胞管线。我们聚焦NAD⁺靶向强化外泌体与干细胞技术的协同应用，重点布局抗衰及组织修复相关领域，构建全面且具创新性的细胞产品体系。
Our pipeline is divided into two core tracks: Immunocyte Pipeline and Stem Cell Pipeline. We focus on the integrated development of NAD⁺-targeted enhanced exosome and stem cell technologies, with a strategic emphasis on anti-aging and tissue repair applications, establishing a comprehensive and innovative cellular product platform.
1. 免疫细胞管线 / Immunocyte Pipeline
以免疫细胞来源产品为核心，依托先进细胞工程技术，研发功能导向的细胞及外泌体产品。
The Immunocyte Pipeline is centered on immunocyte-derived products. Leveraging advanced cell engineering technologies, we develop function-oriented cellular and exosome products with well-defined biological profiles.
核心免疫细胞：NKT细胞来源产品、CAR-T细胞来源产品、CAR-NK细胞来源产品
Core Immunocytes：NKT cell–derived products, CAR-T cell–derived products, and CAR-NK cell–derived products.
衍生外泌体：NKT细胞、CAR-T细胞、CAR-NK细胞来源的NAD⁺靶向强化外泌体（通过工艺优化，大幅提升生物活性与体内稳定性）
Derived Exosomes：NAD⁺-targeted enhanced exosomes derived from NKT cells, CAR-T cells, and CAR-NK cells, developed through process optimization to effectively enhance bioactivity and in vivo stability.
2. 干细胞管线 / Stem Cell Pipeline
以优质来源的间充质干细胞（MSC）为核心，结合NAD⁺靶向强化技术，聚焦抗衰及组织修复应用场景，打造多元化干细胞及衍生外泌体产品。
The Stem Cell Pipeline is built upon high-quality mesenchymal stem cells (MSCs) and integrated with NAD⁺-targeted enhancement technology. This pipeline focuses on anti-aging and tissue repair–related applications, enabling the development of a diversified portfolio of stem cell–based and exosome-derived products.
核心干细胞：骨髓来源间充质干细胞（BM-MSCs）、脐带来源间充质干细胞（UC-MSCs）
Core Stem Cells：Bone marrow–derived mesenchymal stem cells (BM-MSCs) and umbilical cord–derived mesenchymal stem cells (UC-MSCs).
衍生外泌体：间充质干细胞NAD⁺靶向强化外泌体（含骨髓间充质干细胞外泌体、脐带间充质干细胞外泌体），适配不同抗衰与修复场景需求。
Derived Exosomes：NAD⁺-targeted enhanced exosomes derived from mesenchymal stem cells, including bone marrow MSC–derived exosomes and umbilical cord MSC–derived exosomes, designed to support diverse anti-aging and tissue repair–related application needs.
核心应用：干细胞与NAD⁺靶向强化外泌体融合抗衰方案，聚焦组织再生、肌肤抗衰及免疫调控三大核心领域，推动组织再生、肌肤抗衰及免疫调控等领域的精准应用探索。
Key Application：Integrated anti-aging strategies combining stem cells and NAD⁺-targeted enhanced exosomes, with a focus on application-oriented exploration across three key areas: tissue regeneration, skin rejuvenation, and immune modulation.